CD4 and neoplasm: In comparison with these mice, the CD4+ T cell-depleted, combination therapy-treated mice did not show additional tumor suppression from day 7 (Fig. 3c), which may be related to the inability of CD4+ T cell-depleted mice to develop TLS.